ASPP Proteins Specifically Stimulate the Apoptotic Function of p53

Antibodies, a laboratory manual

(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,318

p53: puzzle and paradigm.Preprint

Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346

Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2

Gorina, S. S., & Pavletich, N. P. (1996) · Science · doi:10.1126/science.274.5289.1001 · Cited by 575

Two cellular proteins that bind to wild-type but not mutant p53.

Iwabuchi, K., Bartel, P. L., Li, B., Marraccino, R. L., & Fields, S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.6098 · Cited by 432

In vivo gene expression profile analysis of human breast cancer progression.

Sgroi, D. C., Teng, S., ROBINSON, G. C., LeVangie, R., Hudson, J. R., & Elkahloun, A. G. (1999) · PubMed · Cited by 390

Differential Activation of Target Cellular Promoters by p53 Mutants with Impaired Apoptotic Function

Ludwig, R. L., Bates, S., & Vousden, K. H. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4952 · Cited by 278

E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction.Preprint

Hsieh, J.-K., Fredersdorf, S., Kouzarides, T., Martin, K., & Lü, X. (1997) · Genes & Development · doi:10.1101/gad.11.14.1840 · Cited by 278

A Mutant p53 That Discriminates between p53-Responsive Genes Cannot Induce Apoptosis

Friedlander, P. A., Haupt, Y., Prives, C. L., & Oren, M. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4961 · Cited by 277

Stimulation of p53-mediated Transcriptional Activation by the p53-binding Proteins, 53BP1 and 53BP2

Iwabuchi, K., Li, B., Massa, H. F., Trask, B. J., Date, T., & Fields, S. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.40.26061 · Cited by 206

p53 mutation with frequent novel codons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

Crook, T., Brooks, L. A., Crossland, S., Osin, P., Barker, K. T., Waller, J., Philp, E., Smith, P. D., Yuluğ, I. G., Peto, J., et al. (1998) · Oncogene · doi:10.1038/sj.onc.1202106 · Cited by 179

Live or let die: the cell's response to p53

Vousden, K. H., & Lü, X. (2002) · Nature reviews. Cancer · doi:10.1038/nrc864 · Cited by 3,231

p21 in cancer: Intricate networks and multiple activities

Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712

Death and anti-death: tumour resistance to apoptosis

Igney, F. H., & Krammer, P. H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc776 · Cited by 2,073

Molecular mechanisms of drug resistance

Longley, D., & Johnston, P. (2005) · The Journal of Pathology · doi:10.1002/path.1706 · Cited by 1,726

Modes of p53 regulation.

Kruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610

The Cell–Cycle Arrest and Apoptotic Functions of p53 in Tumor Initiation and Progression

Chen, J. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026104 · Cited by 1,222

The multiple mechanisms that regulate p53 activity and cell fate

Hafner, A., Bulyk, M. L., Jambhekar, A., & Lahav, G. (2019) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-019-0110-x · Cited by 1,129

Apoptosis - the p53 network

Haupt, S., Berger, M., Goldberg, Z., & Haupt, Y. (2003) · Journal of Cell Science · doi:10.1242/jcs.00739 · Cited by 1,136

Decision making by p53: life, death and cancer

Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,085

Targeting p53 pathways: mechanisms, structures, and advances in therapy

Wang, H., Guo, M., Wei, H., & Chen, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01347-1 · Cited by 1,016

The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.

Gartel, A. L., & Tyner, A. L. (2002) · PubMed · Cited by 918

Understanding the function–structure and function–mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis

Kato, S., Han, S., Liu, W., Otsuka, K., Shibata, H., Kanamaru, R., & Ishioka, C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1431692100 · Cited by 895

Akt Phosphorylates the Yes-Associated Protein, YAP, to Induce Interaction with 14-3-3 and Attenuation of p73-Mediated Apoptosis

Basu, S., Totty, N. F., Irwin, M. S., Sudol, M., & Downward, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(02)00776-1 · Cited by 843

Acetylation of the p53 DNA-binding domain regulates apoptosis induction.

Sykes, S. M., Mellert, H. S., Holbert, M. A., Li, K., Marmorstein, R., Lane, W. S., & McMahon, S. B. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.026 · Cited by 752

Ubiquitination, phosphorylation and acetylation: the molecular basis for p53 regulation

Brooks, C. L., & Gu, W. J. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00003-6 · Cited by 746

Role of p53 in Cell Death and Human Cancers

Ozaki, T., & Nakagawara, A. (2011) · Cancers · doi:10.3390/cancers3010994 · Cited by 650

Drugging the p53 pathway: understanding the route to clinical efficacy

Khoo, K. H., Verma, C. S., & Lane, D. P. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4236 · Cited by 742

MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells

Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1305 · Cited by 705

The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions

Borner, C. (2002) · Molecular Immunology · doi:10.1016/s0161-5890(02)00252-3 · Cited by 709

Apoptosis: a basic biological phenomenon with wide‐ranging implications in human disease

Fadeel, B., & Orrenius, S. (2005) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2005.01570.x · Cited by 727

Functional Diversity of Protein Phosphatase-1, a Cellular Economizer and Reset Button

Ceulemans, H., & Bollen, M. (2004) · Physiological Reviews · doi:10.1152/physrev.00013.2003 · Cited by 692

Activation of p53 by MEG3 Non-coding RNA

Zhou, Y., Zhong, Y., Wang, Y., Zhang, X., Batista, D. L., Gejman, R., Ansell, P. J., Zhao, J. C., Weng, C., & Klibanski, A. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702029200 · Cited by 665

Transcriptional Regulation by P53

Beckerman, R., & Prives, C. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000935 · Cited by 569

The expanding universe of p53 targets

Menendez, D., Inga, A., & Resnick, M. A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2730 · Cited by 568

The role of p53 in determining sensitivity to radiotherapy

Gudkov, A. V., & Komarova, E. A. (2003) · Nature reviews. Cancer · doi:10.1038/nrc992 · Cited by 581

p53 and E2f: partners in life and death

Polager, S., & Ginsberg, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2718 · Cited by 498

p63 and p73: Roles in Development and Tumor Formation

Moll, U. M., & Slade, N. (2004) · Molecular Cancer Research · doi:10.1158/1541-7786.371.2.7 · Cited by 488

BCL2 family in DNA damage and cell cycle control

Zinkel, S. S., Gross, A., & Yang, E. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401987 · Cited by 479

Dissecting p53-dependent apoptosis

Chipuk, J. E., & Green, D. R. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401908 · Cited by 462

A complex barcode underlies the heterogeneous response of p53 to stress

Murray-Zmijewski, F., Slee, E. A., & Lu, X. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2451 · Cited by 420

Structural Basis of DNA Recognition by p53 Tetramers

Kitayner, M., Rozenberg, H., Kessler, N., Rabinovich, D., Shaulov, L., Haran, T. E., & Shakked, Z. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.015 · Cited by 408

The transcriptional targets of p53 in apoptosis control

Yu, J., & Zhang, L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.189 · Cited by 427

The p53 pathway in breast cancer

Gasco, M., Shami, S. K., & Crook, T. (2002) · Breast Cancer Research · doi:10.1186/bcr426 · Cited by 410

iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human

Bergamaschi, D., Samuels, Y., O’Neil, N. J., Trigiante, G., Crook, T., Hsieh, J.-K., O’Connor, D. J., Zhong, S., Campargue, I., Tomlinson, M. L., et al. (2003) · Nature Genetics · doi:10.1038/ng1070 · Cited by 376

Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm

Soussi, T., & Wiman, K. G. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.001 · Cited by 375

Activation of the p53 tumor suppressor protein

Vousden, K. H. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00035-5 · Cited by 337

The role of p53 in chemosensitivity and radiosensitivity

El‐Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206949 · Cited by 337

Yes-associated protein (YAP) functions as a tumor suppressor in breast

Yuan, M., Tomlinson, V., Lara, R., Holliday, D. L., Chelala, C., Harada, T., Gangeswaran, R., Bishop, C. L., Smith, P., Danovi, S. A., et al. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.108 · Cited by 336

The p53 response to DNA damage

Meek, D. W. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.027 · Cited by 329

The Role of p53 Signaling in Colorectal Cancer

Liebl, M. C., & Hofmann, T. G. (2021) · Cancers · doi:10.3390/cancers13092125 · Cited by 350

Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development

Migliorini, D., Denchi, E. L., Danovi, D., Jochemsen, A., Capillo, M., Gobbi, A., Helin, K., Pelicci, P. G., & Marine, J.-C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.15.5527-5538.2002 · Cited by 313

The p53 family and programmed cell death

Pietsch, E. C., Sykes, S. M., McMahon, S. B., & Murphy, M. E. (2008) · Oncogene · doi:10.1038/onc.2008.315 · Cited by 331

Molecular Pathogenesis of Euthyroid and Toxic Multinodular Goiter

Krohn, K., Führer, D., Bayer, Y., Eszlinger, M., Brauer, V. F. H., Neumann, S., Paschke, R., & Führer‐Sakel, D. (2004) · Endocrine Reviews · doi:10.1210/er.2004-0005 · Cited by 312

Life and death decisions by the E2F transcription factors

Iaquinta, P. J., & Lees, J. A. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.10.006 · Cited by 304

Cell-to-cell variation in p53 dynamics leads to fractional killing.

Paek, A. L., Liu, J. C., Loewer, A., Forrester, W. C., & Lahav, G. (2016) · Cell · doi:10.1016/j.cell.2016.03.025 · Cited by 292

A Distinctive DNA Damage Response in Human Hematopoietic Stem Cells Reveals an Apoptosis-Independent Role for p53 in Self-Renewal

Milyavsky, M., Gan, O. I., Trottier, M., Komosa, M., Tabach, O., Notta, F., Lechman, E. R., Hermans, K. G., Eppert, K., Konovalova, Z., et al. (2010) · Cell stem cell · doi:10.1016/j.stem.2010.05.016 · Cited by 289

Epithelial cell polarity: a major gatekeeper against cancer?

Royer, C., & Lu, X. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.60 · Cited by 287

Hepatitis B virus x protein in the pathogenesis of hepatitis B virus‐induced hepatocellular carcinoma

Kew, M. C. (2011) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2010.06546.x · Cited by 280

To die or not to die: how does p53 decide?

Slee, E. A., O’Connor, D. J., & Lü, X. (2004) · Oncogene · doi:10.1038/sj.onc.1207516 · Cited by 282

Functional regulation of p73 and p63: development and cancer

Melino, G. (2003) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2003.10.004 · Cited by 284

p53 mutation heterogeneity in cancer

Soussi, T., & Lozano, G. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.03.190 · Cited by 282

A peptide that binds and stabilizes p53 core domain: Chaperone strategy for rescue of oncogenic mutants

Friedler, A., Hansson, L. O., Veprintsev, D. B., Freund, S. M. V., Rippin, T. M., Nikolova, P. V., Proctor, M. R., Rüdiger, S., & Fersht, A. R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241629998 · Cited by 268

p53 Functions through Stress- and Promoter-Specific Recruitment of Transcription Initiation Components before and after DNA Damage

Espinosa, J. M., Verdun, R. E., & Emerson, B. M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00359-9 · Cited by 256

iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72–polymorphic p53

Bergamaschi, D., Samuels, Y., Sullivan, A., Zvelebil, M., Breyssens, H., Bisso, A., Sal, G. D., Syed, N., Smith, P. D., Gasco, M., et al. (2006) · Nature Genetics · doi:10.1038/ng1879 · Cited by 260

Helicobacter pylori cytotoxin-associated gene A (CagA) subverts the apoptosis-stimulating protein of p53 (ASPP2) tumor suppressor pathway of the host

Buti, L., Spooner, E., Van der Veen, A. G., Rappuoli, R., Covacci, A., & Ploegh, H. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106200108 · Cited by 253

Targeting p53 for Novel Anticancer Therapy

Wang, Z., & Sun, Y. (2010) · Translational Oncology · doi:10.1593/tlo.09250 · Cited by 256

Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response

Wei, X., Xu, H., & Kufe, D. W. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.01.008 · Cited by 234

STAT-1 Interacts with p53 to Enhance DNA Damage-induced Apoptosis

Townsend, P. A., Scarabelli, T. M., Davidson, S. M., Knight, R. A., Latchman, D. S., & Stephanou, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m302637200 · Cited by 233

p53 alterations in human cancer: more questions than answers

Soussi, T. (2007) · Oncogene · doi:10.1038/sj.onc.1210280 · Cited by 236

ASPP1 and ASPP2: Common Activators of p53 Family Members

Bergamaschi, D., Samuels, Y., Jin, B., Duraisingham, S., Crook, T., & Lü, X. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1341-1350.2004 · Cited by 229

p53-family proteins and their regulators: hubs and spokes in tumor suppression

Collavin, L., Lunardi, A., & Sal, G. D. (2010) · Cell Death and Differentiation · doi:10.1038/cdd.2010.35 · Cited by 225

Genetic analysis of radiation-induced changes in human gene expression

Smirnov, D., Morley, M., Shin, E., Spielman, R., & Cheung, V. (2009) · Nature · doi:10.1038/nature07940 · Cited by 221

ASPP: a new family of oncogenes and tumour suppressor genes

Sullivan, A., & Lü, X. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603525 · Cited by 215

Comparative Binding of p53 to its Promoter and DNA Recognition Elements

Weinberg, R. L., Veprintsev, D. B., Bycroft, M., & Fersht, A. R. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.014 · Cited by 211

Differential Transactivation by the p53 Transcription Factor Is Highly Dependent on p53 Level and Promoter Target Sequence

Inga, A., Storici, F., Darden, T. A., & Resnick, M. A. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.24.8612-8625.2002 · Cited by 195

Cellular UV damage responses—Functions of tumor suppressor p53

Latonen, L., & Laiho, M. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.04.003 · Cited by 200

Outcomes of p53 activation - spoilt for choice

Vousden, K. H. (2006) · Journal of Cell Science · doi:10.1242/jcs.03293 · Cited by 192

iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding

Ge, W., Zhao, K., Wang, X., Li, H., Yu, M., He, M., Xue, X., Zhu, Y., Zhang, C. L., Cheng, Y., et al. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.09.008 · Cited by 188

Reactivation of mutant p53: molecular mechanisms and therapeutic potential

Selivanova, G., & Wiman, K. G. (2007) · Oncogene · doi:10.1038/sj.onc.1210295 · Cited by 186

53BP1 Integrates DNA Repair and p53-Dependent Cell Fate Decisions via Distinct Mechanisms

Cuella-Martin, R., Oliveira, C., Lockstone, H. E., Snellenberg, S., Grolmusova, N., & Chapman, J. R. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.002 · Cited by 194

Regulating the p53 system through ubiquitination

Yang, Y., Li, C.-C. H., & Weissman, A. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207411 · Cited by 184

Are interactions with p63 and p73 involved in mutant p53 gain of oncogenic function?

Li, Y., & Prives, C. L. (2007) · Oncogene · doi:10.1038/sj.onc.1210311 · Cited by 174

Cellular senescence in the aging and diseased kidney

Valentijn, F. A., Falke, L. L., Nguyen, T. Q., & Goldschmeding, R. (2018) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0434-2 · Cited by 173

hCAS/CSE1L Associates with Chromatin and Regulates Expression of Select p53 Target Genes

Tanaka, T., Ohkubo, S., Tatsuno, I., & Prives, C. L. (2007) · Cell · doi:10.1016/j.cell.2007.08.001 · Cited by 173

MDM2-Dependent Downregulation of p21 and hnRNP K Provides a Switch between Apoptosis and Growth Arrest Induced by Pharmacologically Activated p53

Enge, M., Bao, W., Hedström, E., Jackson, S. P., Moumen, A., & Selivanova, G. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.019 · Cited by 172

Computational Identification of a p38SAPK-Regulated Transcription Factor Network Required for Tumor Cell Quiescence

Adam, A. P., George, A. D., Schewe, D. M., Bragado, P., Iglesias, B. V., Ranganathan, A. C., Kourtidis, A., Conklin, D. S., & Aguirre‐Ghiso, J. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3820 · Cited by 177

Restoring p53 Function in Human Melanoma Cells by Inhibiting MDM2 and Cyclin B1/CDK1-Phosphorylated Nuclear iASPP

Lu, M. M., Breyssens, H., Salter, V., Zhong, S., Hu, Y., Baer, C., Ratnayaka, I., Sullivan, A., Brown, N. R., Endicott, J., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.013 · Cited by 166

The p53 network in head and neck cancer

Gasco, M., & Crook, T. (2003) · Oral Oncology · doi:10.1016/s1368-8375(02)00163-x · Cited by 156

Hzf Determines Cell Survival upon Genotoxic Stress by Modulating p53 Transactivation

Das, S., Raj, L., Zhao, B., Kimura, Y., Bernstein, A., Aaronson, S. A., & Lee, S. W. (2007) · Cell · doi:10.1016/j.cell.2007.06.013 · Cited by 160

Hepatitis B Virus X Protein-Induced Aberrant Epigenetic Modifications Contributing to Human Hepatocellular Carcinoma Pathogenesis

Tian, Y., Yang, W., Song, J. J., Wu, Y., & Ni, B. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00205-13 · Cited by 155

STAT‐1: a novel regulator of apoptosis

Stephanou, A., & Latchman, D. S. (2003) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2003.00363.x · Cited by 152

The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP

Mantovani, F., Tocco, F., Girardini, J. E., Smith, P., Gasco, M., Lü, X., Crook, T., & Sal, G. D. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1306 · Cited by 155

Another fork in the road—life or death decisions by the tumour suppressor p53

Carvajal, L. A., & Manfredi, J. J. (2013) · The EMBO Reports · doi:10.1038/embor.2013.25 · Cited by 149

Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressorPreprint

Lilyestrom, W. G., Klein, M. G., Zhang, R., Joachimiak, A., & Chen, X. S. (2006) · Genes & Development · doi:10.1101/gad.1456306 · Cited by 147

Hepatitis B virus, HBx mutants and their role in hepatocellular carcinoma

Ali, A. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i30.10238 · Cited by 147

SIRT1 interacts with p73 and suppresses p73‐dependent transcriptional activity

Dai, J. M., Wang, Z. Y., Sun, D. C., Lin, R. X., & Wang, S. Q. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20831 · Cited by 157

ASPP2 controls epithelial plasticity and inhibits metastasis through β-catenin-dependent regulation of ZEB1

Wang, Y., Bu, F., Royer, C., Serres, S., Larkin, J. R., Soto, M. S., Sibson, N. R., Salter, V., Fritzsche, F. R., Turnquist, C., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3050 · Cited by 145

Involvement of 14-3-3 Signaling Protein Binding in the Functional Regulation of the Transcriptional Activator REPRESSION OF SHOOT GROWTH by Gibberellins

Ishida, S., Fukazawa, J., Yuasa, T., & Takahashi, Y. (2004) · The Plant Cell · doi:10.1105/tpc.104.024604 · Cited by 145

Identification of p53 regulators by genome-wide functional analysis

Huang, Q., Raya, Á., DeJesus, P., Chao, S., Quon, K. C., Caldwell, J. S., Chanda, S. K., Izpisúa‐Belmonte, J. C., & Schultz, P. G. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308562100 · Cited by 144

Apoptosis in cancer—implications for therapy

Schulze‐Bergkamen, H., & Krammer, P. H. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2003.11.006 · Cited by 146

PP1 Cooperates with ASPP2 to Dephosphorylate and Activate TAZ

Liu, C., Lv, X., Li, T., Xu, Y., Zhou, X., Zhao, S., Xiong, Y., Lei, Q., & Guan, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.194019 · Cited by 140

Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival

Zaman, M. S., Shahryari, V., Deng, G., Thamminana, S., Saini, S., Majid, S., Chang, I., Hirata, H., Ueno, K., Yamamura, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031060 · Cited by 138

Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer–related mechanisms in colon cancer cells in vitro

van Erk, M. J., Roepman, P., van der Lende, T. R., Stierum, R. H., Aarts, J. M. M. J. G., van BLADEREN, P. J., & van Ommen, B. (2004) · European Journal of Nutrition · doi:10.1007/s00394-004-0503-1 · Cited by 136

Coiled-coil protein composition of 22 proteomes – differences and common themes in subcellular infrastructure and traffic control

Rose, A., Schraegle, S. J., Stahlberg, E. A., & Meier, I. (2005) · BMC Evolutionary Biology · doi:10.1186/1471-2148-5-66 · Cited by 138

ASPPs and cancer

Trigiante, G., & Lü, X. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1818 · Cited by 135

Tumor suppressor p53 and its gain-of-function mutants in cancer

Liu, J., Zhang, C., & Feng, Z. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmt144 · Cited by 133

Groups of p53 target genes involved in specific p53 downstream effects cluster into different classes of DNA binding sites

Hua, Q., Wang, T., Naumovski, L., Lopez, C. D., & Brachmann, R. K. (2002) · Oncogene · doi:10.1038/sj.onc.1205974 · Cited by 123

Small molecules that reactivate mutant p53

Bykov, V. J. N., Selivanova, G., & Wiman, K. G. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00454-4 · Cited by 123

A New Inhibitor of Apoptosis from Vaccinia Virus and Eukaryotes

Keller, C. G., Bergamaschi, D., Hollinshead, M. S., Lü, X., van Kuppeveld, F. J. M., & Smith, G. L. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030017 · Cited by 122

The recently discovered Apoptosis Stimulating Proteins of p53

Sullivan, A., & Lu, X. (2013)

ASPP: a new family of oncogenes and tumour suppressor genes

Sullivan, A., & Lü, X. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603525 · Cited by 215

ASPPs and cancer

Trigiante, G., & Lü, X. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1818 · Cited by 135

ASPP--Apoptotic specific regulator of p53.

Liu, Z.-J., Lu, X., & Zhong, S. (2005) · Biochimica et Biophysica Acta · doi:10.1016/j.bbcan.2005.08.002 · Cited by 26

ASPP1 and ASPP2: Common Activators of p53 Family Members

Bergamaschi, D., Samuels, Y., Jin, B., Duraisingham, S., Crook, T., & Lü, X. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1341-1350.2004 · Cited by 229